↓ Skip to main content

Cochrane Database of Systematic Reviews

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

Overview of attention for article published in Cochrane database of systematic reviews, June 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
146 Mendeley
citeulike
1 CiteULike
Title
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
Published in
Cochrane database of systematic reviews, June 2014
DOI 10.1002/14651858.cd009120.pub2
Pubmed ID
Authors

Ling Zhang, Xiaoxi Zeng, Ping Fu, Hong Mei Wu

Abstract

Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are widely used in peritoneal dialysis (PD) patients, yet controversy exists about their impact on residual kidney function.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 1 <1%
Brunei Darussalam 1 <1%
Canada 1 <1%
Unknown 143 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 15%
Researcher 18 12%
Student > Ph. D. Student 16 11%
Student > Bachelor 14 10%
Student > Postgraduate 10 7%
Other 26 18%
Unknown 40 27%
Readers by discipline Count As %
Medicine and Dentistry 61 42%
Nursing and Health Professions 11 8%
Economics, Econometrics and Finance 5 3%
Agricultural and Biological Sciences 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 14 10%
Unknown 47 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2020.
All research outputs
#7,944,382
of 25,382,360 outputs
Outputs from Cochrane database of systematic reviews
#9,167
of 12,583 outputs
Outputs of similar age
#71,835
of 240,656 outputs
Outputs of similar age from Cochrane database of systematic reviews
#175
of 220 outputs
Altmetric has tracked 25,382,360 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 12,583 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.9. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,656 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 220 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.